Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Free Circulating Tumor Cell Detection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4661937
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 100 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Free Circulating Tumor Cell Detection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Free circulating tumor cell detection is a method of isolating and detecting tumor cells from the patient's peripheral blood. These tumor cells fall off from primary or metastatic tumors and enter the blood circulation. CTC detection technology captures these cells through physical or biomarker methods for early diagnosis, efficacy monitoring, recurrence warning and prognosis evaluation of cancer. This non-invasive test can provide tumor characteristic information, help personalized treatment and dynamically track disease progression.
This report is a detailed and comprehensive analysis for global Free Circulating Tumor Cell Detection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Free Circulating Tumor Cell Detection market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Free Circulating Tumor Cell Detection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Free Circulating Tumor Cell Detection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Free Circulating Tumor Cell Detection market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Free Circulating Tumor Cell Detection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Free Circulating Tumor Cell Detection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Free Circulating Tumor Cell Detection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Protein Marker Detection
Gene Marker Detection
RNA Detection
Market segment by Application
Hospital
Physical Examination Center
Major players covered
Rarecyte
ANGLE plc
Biocept Inc.
Bio-Rad Laboratories Inc.
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen
Thermo Fisher Scientific
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Free Circulating Tumor Cell Detection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Free Circulating Tumor Cell Detection, with price, sales quantity, revenue, and global market share of Free Circulating Tumor Cell Detection from 2020 to 2025.
Chapter 3, the Free Circulating Tumor Cell Detection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Free Circulating Tumor Cell Detection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Free Circulating Tumor Cell Detection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Free Circulating Tumor Cell Detection.
Chapter 14 and 15, to describe Free Circulating Tumor Cell Detection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Free Circulating Tumor Cell Detection Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Protein Marker Detection
    • 1.3.3 Gene Marker Detection
    • 1.3.4 RNA Detection
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Free Circulating Tumor Cell Detection Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Physical Examination Center
  • 1.5 Global Free Circulating Tumor Cell Detection Market Size & Forecast
    • 1.5.1 Global Free Circulating Tumor Cell Detection Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Free Circulating Tumor Cell Detection Sales Quantity (2020-2031)
    • 1.5.3 Global Free Circulating Tumor Cell Detection Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Rarecyte
    • 2.1.1 Rarecyte Details
    • 2.1.2 Rarecyte Major Business
    • 2.1.3 Rarecyte Free Circulating Tumor Cell Detection Product and Services
    • 2.1.4 Rarecyte Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Rarecyte Recent Developments/Updates
  • 2.2 ANGLE plc
    • 2.2.1 ANGLE plc Details
    • 2.2.2 ANGLE plc Major Business
    • 2.2.3 ANGLE plc Free Circulating Tumor Cell Detection Product and Services
    • 2.2.4 ANGLE plc Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 ANGLE plc Recent Developments/Updates
  • 2.3 Biocept Inc.
    • 2.3.1 Biocept Inc. Details
    • 2.3.2 Biocept Inc. Major Business
    • 2.3.3 Biocept Inc. Free Circulating Tumor Cell Detection Product and Services
    • 2.3.4 Biocept Inc. Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Biocept Inc. Recent Developments/Updates
  • 2.4 Bio-Rad Laboratories Inc.
    • 2.4.1 Bio-Rad Laboratories Inc. Details
    • 2.4.2 Bio-Rad Laboratories Inc. Major Business
    • 2.4.3 Bio-Rad Laboratories Inc. Free Circulating Tumor Cell Detection Product and Services
    • 2.4.4 Bio-Rad Laboratories Inc. Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Bio-Rad Laboratories Inc. Recent Developments/Updates
  • 2.5 Fluxion Biosciences Inc.
    • 2.5.1 Fluxion Biosciences Inc. Details
    • 2.5.2 Fluxion Biosciences Inc. Major Business
    • 2.5.3 Fluxion Biosciences Inc. Free Circulating Tumor Cell Detection Product and Services
    • 2.5.4 Fluxion Biosciences Inc. Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Fluxion Biosciences Inc. Recent Developments/Updates
  • 2.6 F. Hoffmann-La Roche AG
    • 2.6.1 F. Hoffmann-La Roche AG Details
    • 2.6.2 F. Hoffmann-La Roche AG Major Business
    • 2.6.3 F. Hoffmann-La Roche AG Free Circulating Tumor Cell Detection Product and Services
    • 2.6.4 F. Hoffmann-La Roche AG Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 F. Hoffmann-La Roche AG Recent Developments/Updates
  • 2.7 Sysmex Europe SE
    • 2.7.1 Sysmex Europe SE Details
    • 2.7.2 Sysmex Europe SE Major Business
    • 2.7.3 Sysmex Europe SE Free Circulating Tumor Cell Detection Product and Services
    • 2.7.4 Sysmex Europe SE Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Sysmex Europe SE Recent Developments/Updates
  • 2.8 Qiagen
    • 2.8.1 Qiagen Details
    • 2.8.2 Qiagen Major Business
    • 2.8.3 Qiagen Free Circulating Tumor Cell Detection Product and Services
    • 2.8.4 Qiagen Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Qiagen Recent Developments/Updates
  • 2.9 Thermo Fisher Scientific
    • 2.9.1 Thermo Fisher Scientific Details
    • 2.9.2 Thermo Fisher Scientific Major Business
    • 2.9.3 Thermo Fisher Scientific Free Circulating Tumor Cell Detection Product and Services
    • 2.9.4 Thermo Fisher Scientific Free Circulating Tumor Cell Detection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Thermo Fisher Scientific Recent Developments/Updates

3 Competitive Environment: Free Circulating Tumor Cell Detection by Manufacturer

  • 3.1 Global Free Circulating Tumor Cell Detection Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Free Circulating Tumor Cell Detection Revenue by Manufacturer (2020-2025)
  • 3.3 Global Free Circulating Tumor Cell Detection Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Free Circulating Tumor Cell Detection by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Free Circulating Tumor Cell Detection Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Free Circulating Tumor Cell Detection Manufacturer Market Share in 2024
  • 3.5 Free Circulating Tumor Cell Detection Market: Overall Company Footprint Analysis
    • 3.5.1 Free Circulating Tumor Cell Detection Market: Region Footprint
    • 3.5.2 Free Circulating Tumor Cell Detection Market: Company Product Type Footprint
    • 3.5.3 Free Circulating Tumor Cell Detection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Free Circulating Tumor Cell Detection Market Size by Region
    • 4.1.1 Global Free Circulating Tumor Cell Detection Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Free Circulating Tumor Cell Detection Consumption Value by Region (2020-2031)
    • 4.1.3 Global Free Circulating Tumor Cell Detection Average Price by Region (2020-2031)
  • 4.2 North America Free Circulating Tumor Cell Detection Consumption Value (2020-2031)
  • 4.3 Europe Free Circulating Tumor Cell Detection Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Free Circulating Tumor Cell Detection Consumption Value (2020-2031)
  • 4.5 South America Free Circulating Tumor Cell Detection Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Free Circulating Tumor Cell Detection Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Free Circulating Tumor Cell Detection Sales Quantity by Type (2020-2031)
  • 5.2 Global Free Circulating Tumor Cell Detection Consumption Value by Type (2020-2031)
  • 5.3 Global Free Circulating Tumor Cell Detection Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Free Circulating Tumor Cell Detection Sales Quantity by Application (2020-2031)
  • 6.2 Global Free Circulating Tumor Cell Detection Consumption Value by Application (2020-2031)
  • 6.3 Global Free Circulating Tumor Cell Detection Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Free Circulating Tumor Cell Detection Sales Quantity by Type (2020-2031)
  • 7.2 North America Free Circulating Tumor Cell Detection Sales Quantity by Application (2020-2031)
  • 7.3 North America Free Circulating Tumor Cell Detection Market Size by Country
    • 7.3.1 North America Free Circulating Tumor Cell Detection Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Free Circulating Tumor Cell Detection Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Free Circulating Tumor Cell Detection Sales Quantity by Type (2020-2031)
  • 8.2 Europe Free Circulating Tumor Cell Detection Sales Quantity by Application (2020-2031)
  • 8.3 Europe Free Circulating Tumor Cell Detection Market Size by Country
    • 8.3.1 Europe Free Circulating Tumor Cell Detection Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Free Circulating Tumor Cell Detection Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Free Circulating Tumor Cell Detection Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Free Circulating Tumor Cell Detection Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Free Circulating Tumor Cell Detection Market Size by Region
    • 9.3.1 Asia-Pacific Free Circulating Tumor Cell Detection Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Free Circulating Tumor Cell Detection Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Free Circulating Tumor Cell Detection Sales Quantity by Type (2020-2031)
  • 10.2 South America Free Circulating Tumor Cell Detection Sales Quantity by Application (2020-2031)
  • 10.3 South America Free Circulating Tumor Cell Detection Market Size by Country
    • 10.3.1 South America Free Circulating Tumor Cell Detection Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Free Circulating Tumor Cell Detection Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Free Circulating Tumor Cell Detection Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Free Circulating Tumor Cell Detection Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Free Circulating Tumor Cell Detection Market Size by Country
    • 11.3.1 Middle East & Africa Free Circulating Tumor Cell Detection Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Free Circulating Tumor Cell Detection Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Free Circulating Tumor Cell Detection Market Drivers
  • 12.2 Free Circulating Tumor Cell Detection Market Restraints
  • 12.3 Free Circulating Tumor Cell Detection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Free Circulating Tumor Cell Detection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Free Circulating Tumor Cell Detection
  • 13.3 Free Circulating Tumor Cell Detection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Free Circulating Tumor Cell Detection Typical Distributors
  • 14.3 Free Circulating Tumor Cell Detection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Free Circulating Tumor Cell Detection. Industry analysis & Market Report on Free Circulating Tumor Cell Detection is a syndicated market report, published as Global Free Circulating Tumor Cell Detection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Free Circulating Tumor Cell Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo